Esophageal Varices

Actionable Insights Powered by AI

Belapectin Shows Promising Reduction in Esophageal Varices in MASH Cirrhosis Patients, Despite Missing Primary Endpoint

Belapectin, MASH Cirrhosis, Portal Hypertension, Esophageal Varices, Clinical Trial, Galectin Therapeutics